AMN Healthcare's fiscal second quarter arrived as the cleanup of a once-in-a-decade labor event. Three months earlier, a multi-event strike mobilization had pushed first-quarter revenue past $1.378 billion, with labor disruption services alone contributing roughly $722 million. That event then unwound. Second-quarter revenue printed at $673 million - a 51% sequential collapse and only a 2% year-over-year gain - with labor disruption revenue down to $25 million, basically back to the $16 million the segment produced a year ago. On the surface, it looked like a one-quarter wonder followed by a return to ordinary decline. The second look says something different. Adjusted EBITDA reached $73 million, up 26% year over year and at the high end of the prior guide, with adjusted EBITDA margin of 10.9% - 200 basis points wider than a year ago and 380 basis points wider sequentially. Adjusted diluted EPS was $0.77, up 157% year over year. The base business underneath the strike - travel nurse, allied, international nurse, locum tenens, search - held up or grew. The narrative the company is selling is that the strike was a *cumulative-quarter* event, not a *cumulative-decade* event: the operational capacity it built is now being redeployed against a demand environment that is, in management's words, "improving through the quarter, with the trend [that] improved in July." Investors at $32.44 a share, after a 52-week run that took the stock from $15.10 in early January to a fresh $36.60 high on August 10, are now weighing whether the underlying franchise has genuinely re-accelerated or whether Q2 was simply the inevitable mean-reversion that has to follow $1.4 billion quarters.
The single most important read in the numbers is the composition of growth underneath the headline. Travel nurse revenue grew roughly 10% year over year on traveler volume that was 5.7% higher than the prior year, with bill rates essentially flat - that is volume, not pricing, and it confirms management's claim that base demand recovered as the strike wound down. Allied grew 8% year over year and 4% sequentially. Search revenue grew 27% year over year, with strength in executive search and physician permanent placement. International nurse staffing continued to grow sequentially and year over year. The Nurse and Allied Solutions segment, the strike channel, was up 11% on the year and 63% *down* sequentially - entirely the labor-disruption unwind. The Physician and Leadership Solutions segment, by contrast, was down 6% year over year and flat sequentially, with locum tenens down 8% on lower days filled. Technology and Workforce Solutions was down 15% on language services pricing pressure and a weaker VMS quarter. Two of the three segments are still shrinking. The third grew entirely on a non-recurring event that has just rolled off. This is a beat quarter wrapped around a franchise that has not yet proven it can grow on its own.
The balance sheet, though, is the part of the story that does not need a second look. Leverage fell to 1.5x at quarter-end, from 3.3x at year-end 2025 - a 1.8-turn improvement in two quarters, achieved through roughly $373 million of year-to-date operating cash flow and a working-capital release as the strike deposits unwound. Total debt remains at $750 million (the 2029 and 2031 senior notes, with $430 million of revolver headroom still available and nothing drawn). Cash of $362 million is up from $34 million at year-end 2025. The leverage step-down is the cleanest piece of evidence that the strike mobilization, even with its Q1 client-deposit volatility, produced real cash and that the company is no longer operating under the credit-watch pressure that hung over it through 2024 and 2025. At roughly 1.3x sales on a true run-rate base, roughly 9x trailing-twelve-month adjusted EPS of approximately $3.50, and 1.7x book, the multiple is a recovery multiple - the market pricing a continued normalization, not a contrarian bet on growth. The test is whether the second-half run-rate supports the multiple as the labor-disruption tailwind continues to fall out of the comparable base.